Daniel C. Edelman, PhD – Biosketch, CGI
As a policy analyst on the Personalized Medicine team in FDA’s Office of In Vitro Diagnostics, within the Center for Devices and Radiological Health, Dr. Edelman is involved in internal and external collaborations, policy development and implementation in areas such as companion diagnostics and oncology related tests. Dr. Edelman also previously served within the Office of In Vitro Diagnostics as a scientific reviewer for IVD devices.
Dr. Edelman holds an MS in Applied Molecular Biology from the University of MD Baltimore County and a PhD in Medical Pathology from University of MD Baltimore. In his career, Dr. Edelman has authored or co-authored 34 peer-reviewed publications and over 55 abstracts with both oral and poster presentations at many scientific meetings.
Prior to his current FDA role, Dr. Edelman was core manager of the Clinical Molecular Profiling Core for 13-years at the National Cancer Institute, NIH. This state-of-the-art genomic CLIA laboratory actively supported translational and clinical cancer research at the NCI and NIH Clinical Center with dozens of research and clinical trial collaborations.
He has also worked as a research associate at the VA Medical Center, Baltimore, MD and as a molecular technologist at the University of MD Medical Center, Baltimore, MD. This work along with his dissertation research contributed towards Dr. Edelman’s 14 years of experience in infectious disease research and diagnostics primarily in the virology of HIV, HCV, and HHV-8, but also in prion diseases.